Hi, what are you looking for?
CEO Payton Nyquvest says the authorization moves his firm closer to developing medicines at scale to support psychedelic-assisted therapy
Currently treatments are largely insufficient, so care providers encourage more research despite stigma
The new facility will feature the firm's ketamine-assisted therapy program, as well as a range of health and lifestyle services
The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine